Literature DB >> 7712700

Undiagnosed glucose intolerance in the community: the Isle of Ely Diabetes Project.

D R Williams1, N J Wareham, D C Brown, C D Byrne, P M Clark, B D Cox, L J Cox, N E Day, C N Hales, C R Palmer.   

Abstract

The Isle of Ely Diabetes Project is a prospective population-based study of the aetiology and pathogenesis of Type 2 diabetes mellitus. Between 1990 and 1992, 1156 subjects aged between 40 and 65 years underwent a standard 75 g oral glucose tolerance test (OGTT). A total of 1122 individuals who were not known to have diabetes completed the test and were classified according to WHO criteria; 51 subjects (4.5%) had previously undiagnosed diabetes and 188 (16.7%) had impaired glucose tolerance. The subjects with newly diagnosed glucose intolerance were significantly older, more obese, and shorter than those with normal glucose tolerance. Blood pressure, cholesterol, triglyceride, and LDL-cholesterol concentrations were elevated and HDL-cholesterol levels were lower among those with abnormal rather than normal glucose tolerance. In multiple regression analyses stratified by gender and including age, body mass index, and the waist-hip ratio as covariates, there were significant differences between those with normal and abnormal glucose intolerance in blood pressure, triglyceride, and HDL-cholesterol, but not total or LDL-cholesterol. In both male and female subjects, height had a significant independent negative association with the plasma glucose at 120 min after administration of oral glucose (standardized beta coefficient = -0.12, p < 0.01).

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7712700     DOI: 10.1111/j.1464-5491.1995.tb02058.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  42 in total

Review 1.  Should we screen for type 2 diabetes? Evaluation against National Screening Committee criteria.

Authors:  N J Wareham; S J Griffin
Journal:  BMJ       Date:  2001-04-21

2.  Evaluation of a risk factor scoring model in screening for undiagnosed diabetes in China population.

Authors:  Jian-jun Dong; Neng-jun Lou; Jia-jun Zhao; Zhong-wen Zhang; Lu-lu Qiu; Ying Zhou; Lin Liao
Journal:  J Zhejiang Univ Sci B       Date:  2011-10       Impact factor: 3.066

3.  Effect of population screening for type 2 diabetes on mortality: long-term follow-up of the Ely cohort.

Authors:  R K Simmons; M Rahman; R W Jakes; M F Yuyun; A R Niggebrugge; S H Hennings; D R R Williams; N J Wareham; S J Griffin
Journal:  Diabetologia       Date:  2010-10-27       Impact factor: 10.122

4.  Estimation of the prevalence of diagnosed diabetes from primary care and secondary care source data: comparison of record linkage with capture-recapture analysis.

Authors:  J N Harvey; L Craney; D Kelly
Journal:  J Epidemiol Community Health       Date:  2002-01       Impact factor: 3.710

5.  The in vivo effects of the Pro12Ala PPARgamma2 polymorphism on adipose tissue NEFA metabolism: the first use of the Oxford Biobank.

Authors:  G D Tan; M J Neville; E Liverani; S M Humphreys; J M Currie; L Dennis; B A Fielding; F Karpe
Journal:  Diabetologia       Date:  2005-12-17       Impact factor: 10.122

6.  The changing classification and diagnosis of diabetes. New classification is based on pathogenesis, not insulin dependence.

Authors:  N J Wareham; S O'Rahilly
Journal:  BMJ       Date:  1998-08-08

Review 7.  Influences of the intrauterine metabolic environment on adult disease: what may we infer from size at birth?

Authors:  L P Purdy; B E Metzger
Journal:  Diabetologia       Date:  1996-09       Impact factor: 10.122

8.  The burden of diabetes-related mortality in France in 2002: an analysis using both underlying and multiple causes of death.

Authors:  Isabelle Romon; Eric Jougla; Beverley Balkau; Anne Fagot-Campagna
Journal:  Eur J Epidemiol       Date:  2008       Impact factor: 8.082

9.  The ADDITION-Cambridge trial protocol: a cluster -- randomised controlled trial of screening for type 2 diabetes and intensive treatment for screen-detected patients.

Authors:  Justin B Echouffo-Tcheugui; Rebecca K Simmons; Kate M Williams; Roslyn S Barling; A Toby Prevost; Ann Louise Kinmonth; Nicholas J Wareham; Simon J Griffin
Journal:  BMC Public Health       Date:  2009-05-12       Impact factor: 3.295

10.  Are people with negative diabetes screening tests falsely reassured? Parallel group cohort study embedded in the ADDITION (Cambridge) randomised controlled trial.

Authors:  Charlotte A M Paddison; Helen C Eborall; Stephen Sutton; David P French; Joana Vasconcelos; A Toby Prevost; Ann-Louise Kinmonth; Simon J Griffin
Journal:  BMJ       Date:  2009-11-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.